Masataka Nakai
Papers
1
Total Citations
7
H-Index
1
About
Masataka Nakai is a radiation oncologist whose work centers on stereotactic ablative body radiotherapy (SABR), with a particular focus on optimizing treatment for metastatic lung tumors using the CyberKnife system. His major contribution lies in demonstrating how this robotic, image-guided platform can deliver a central high dose to gross tumor volumes while maintaining steep dose gradients, thereby sparing surrounding healthy tissue and enhancing therapeutic efficacy. This approach addresses a critical challenge in radiotherapy: balancing dose escalation for tumor control with the minimization of toxicity. Nakai’s most-cited paper, published in 2023, has already garnered 7 citations, reflecting the immediate relevance of his findings to clinical practice. His research is notable for its technical precision and translational impact, offering a refined strategy for patients with oligometastatic lung disease who may not be candidates for surgery. By advancing the application of CyberKnife SABR, Nakai contributes to the broader goal of personalizing radiation therapy, improving outcomes for a vulnerable patient population.
Research Focus
Key Achievements
Top Papers
- 1